AmCad BioMed announced on the 23rd that its newly developed overnight-free ultrasound smart sleep detection device, the "AmCAD-UO," has obtained the self-pay code from the Taipei City Health Bureau. It will be introduced for use in the Health Management Center of National Taiwan University Hospital, Goodheart Clinic, Harvard Wealth Clinic, and Sunshine Internal Medicine Clinic. AmCad stated that this intelligent medical device is now available in all medical institutions in Taipei City, which will facilitate applications for self-pay codes from other county and city health bureaus and enable access to medical institutions nationwide.
Yi-Li Lee, General Manager of AmCad, pointed out that after obtaining the self-pay code from the Taichung City Health Bureau, AmCad's "AmCAD-UO" has recently received approval from the Taipei City Health Bureau. The device was originally introduced for use in health check-ups at China Medical University Hospital, and now medical institutions in Taipei City, including the Health Management Center of National Taiwan University Hospital and Goodheart Clinic, can also introduce and use it. In the future, it will gradually enter more medical and health examination units to safeguard people's sleep health, detect and treat early, and reduce the risk of related diseases.
In our country, over a million people suffer from sleep apnea, with obstructive sleep apnea (OSA) being the most common, severely affecting physical health. For severe patients, the mortality rate is 2.6 times higher than that of normal individuals, and the risk of hypertension is 1.5 times higher. Decreased sleep quality also leads to a 2.5 times higher rate of traffic accidents.
What is worrisome is that up to 75% of severe patients remain undiagnosed, mainly due to traditional sleep tests requiring an overnight stay at sleep centers, with limited beds and waiting times often exceeding six months, reducing willingness to undergo testing.
AmCad's ultrasound smart sleep detection device, which is newly developed and on the market, features overnight-free testing and completion within ten minutes. Clinical research conducted in collaboration with the Health Management Center of National Taiwan University Hospital has found that for detected severe patients, further examination at sleep centers yields an accuracy rate of up to 95%. Additionally, international cooperation with Stanford Sleep Center in the United States has confirmed an accuracy rate of over 90%, with the latest collaborative results being published in the top-ranked medical journal in the global otolaryngology field, JAMA Otolaryngology. The latest collaborative results have also been submitted to top-tier international journals in the field of sleep.
Resource (Mandarin):
